$AUPH I know all the talk is about VOC for LN, but it's worth taking a look at the current DES trial and corresponding market opportunity for DES. If successful, DES alone could justify pps north of 20. at some point, that has to be factored into valuation. I recall Glick talked about wrapping that one up for partnership or sale one of the CCs. WT
  • 2
  • 4